Product Description
SHIKARI® Q-PEM ELISA Kit: Enzyme immunoassay for the quantitative determination of pembrolizumab (Keytruda®) in serum and plasma. Matriks Biotek® pembrolizumab ELISA has been especially developed for the quantitative analysis pembrolizumab in serum and plasma samples between the Cmin and Cmax range of concentrations indicated in the pharmacokinetics section of prospectus.
Specifications:
Required Volume (µl) | 10 |
Total Time (min) | 140 |
Sample | Serum, Plasma |
Sample Number | 96 |
Detection Limit (ng/mL) | 30 |
Spike Recovery (%) | Between 85-115 |
Shelf Life (year) | 1 |
Documentation
Download IFU
Download MSDS
Please note that the documentation provided is for reference use only. For the most updated version, please contact us.
For Research Use Only
Manufactured by Matriks Biotek Co.
Questions about this product? Ready to place an order? Email us at orders@iwai-chem.com or give us a call: (650) 486-1541 |